Dr. Seethal Jacob shares advice to help improve research funding for sickle cell disease and how patients can help improve SCD care.

Does renal medullary carcinoma have a clear relationship with sickle cell? Watch as expert Dr. Kimryn Rathmell explains situations that can lead to RMC and what can occur with sickle cells in the tissues of the kidneys.

Renal medullary carcinoma treatment options have been expanding. Watch as expert Dr. Kimryn Rathmell shares information about current treatment options and exciting research efforts that are under study for RMC care.

What are some known conditions linked with renal medullary carcinoma? Watch as expert Dr. Kimryn Rathmell explains conditions that can be RMC risk factors and those that she examines further in patients to rule out RMC.

Renal medullary carcinoma may not be on the radar of all primary care providers. Watch as expert Dr. Kimryn Rathmell provides advice on questions those with sickle cell trait can ask their doctors.

What can predispose sickle cell patients to renal medullary carcinoma (RMC)? Watch as expert Dr. Kimryn Rathmell shares situations that can predispose those with sickle cell to RMC and symptoms that can signal RMC.

Renal medullary carcinoma care involves a team of experts. Watch as expert Dr. Kimryn Rathmell gives an overview of the team members integral in RMC diagnosis and patient care.

Does kidney cancer have screening options like breast cancer and prostate cancer? Watch as expert Dr. Kimryn Rathmell explains improvements needed for kidney cancer detection and awareness.

Renal medullary carcinoma can be challenging to diagnose. Watch as expert Dr. Kimryn Rathmell shares specific challenges with RMC diagnosis and symptoms that may be warning signs of RMC.

Renal medullary carcinoma and renal cell carcinoma possess some key differences. Watch as expert Dr. Kimryn Rathmell explains how the carcinomas differ.

Renal medullary carcinoma research has had some recent wins but still has room for improvements. Watch as expert Dr. Kimryn Rathmell shares updates about investigation and funding RMC research.

• The molecular profile of RMC distinguishes it from other renal malignancies

• RMC harbors a high number of focal chromosomal alterations

• RMC has a distinct immune profile characterized by upregulation of cGAS-STING

• DNA replication stress is a hallmark of RMC that can be therapeutically targeted

Dr. Pavlos Msaouel speaks on the relationship between advanced or aggressive cancers, such as renal medullary carcinoma (RMC) and the novel coronavirus, COVID-19.

Dr. Pavlos Msaouel shares how patients can effectively self-advocate if diagnosed with renal medullary carcinoma (RMC).

Dr. Pavlos Msaouel breaks down the steps patients can take to detect renal medullary carcinoma (RMC) early.

Dr. Pavlos Msaouel broaches the disparities that exist for patients with renal medullary carcinoma (RMC).

Dr. Pavlos Msaouel gives an overview of RMC, a rare, deadly type of kidney cancer predominantly afflicting young adults of African decent with sickle cell disease.